GR3025679T3 - Vaccines - Google Patents

Vaccines

Info

Publication number
GR3025679T3
GR3025679T3 GR970403328T GR970403328T GR3025679T3 GR 3025679 T3 GR3025679 T3 GR 3025679T3 GR 970403328 T GR970403328 T GR 970403328T GR 970403328 T GR970403328 T GR 970403328T GR 3025679 T3 GR3025679 T3 GR 3025679T3
Authority
GR
Greece
Prior art keywords
vaccines
liposomes
animal
binding
human
Prior art date
Application number
GR970403328T
Other languages
English (en)
Inventor
Martin James Ford
Original Assignee
Evans Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evans Medical Ltd filed Critical Evans Medical Ltd
Publication of GR3025679T3 publication Critical patent/GR3025679T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
GR970403328T 1990-08-24 1997-12-16 Vaccines GR3025679T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909018690A GB9018690D0 (en) 1990-08-24 1990-08-24 Vaccines
PCT/GB1991/001426 WO1992003162A1 (en) 1990-08-24 1991-08-23 Vaccines

Publications (1)

Publication Number Publication Date
GR3025679T3 true GR3025679T3 (en) 1998-03-31

Family

ID=10681227

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970403328T GR3025679T3 (en) 1990-08-24 1997-12-16 Vaccines

Country Status (9)

Country Link
EP (1) EP0546036B1 (el)
JP (1) JP3396478B2 (el)
AT (1) ATE159173T1 (el)
DE (1) DE69127975T2 (el)
DK (1) DK0546036T3 (el)
ES (1) ES2112275T3 (el)
GB (1) GB9018690D0 (el)
GR (1) GR3025679T3 (el)
WO (1) WO1992003162A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AU2520595A (en) * 1994-05-31 1995-12-21 Inex Pharmaceuticals Corp. Virosome-mediated intracellular delivery of therapeutic agents
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
EP0969826A1 (en) * 1997-03-11 2000-01-12 Stichting Dienst Landbouwkundig Onderzoek Use of liposomes containing a chelating agent, a fungicide or a secropine for improving mucosal vaccination
AR059972A1 (es) * 2006-03-22 2008-05-14 Solvay Pharm Bv Administracion intranasal o inhalacional de virosomas
US8535683B2 (en) 2006-03-22 2013-09-17 Abbott Biologicals B.V. Intranasal or inhalational administration of virosomes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE661402A (el) * 1964-03-20
SU579309A1 (ru) * 1973-11-16 1977-11-05 Ленинградский Политехнический Институт Им.М.И.Калинина Способ получени вакцины
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
JPH04500203A (ja) * 1988-08-25 1992-01-16 ザ　リポソーム　カンパニー，インコーポレイテッド インフルエンザワクチンおよび新規なアジュバント

Also Published As

Publication number Publication date
ATE159173T1 (de) 1997-11-15
GB9018690D0 (en) 1990-10-10
EP0546036B1 (en) 1997-10-15
DE69127975T2 (de) 1998-02-12
JP3396478B2 (ja) 2003-04-14
ES2112275T3 (es) 1998-04-01
EP0546036A1 (en) 1993-06-16
DK0546036T3 (da) 1997-11-03
WO1992003162A1 (en) 1992-03-05
DE69127975D1 (de) 1997-11-20
JPH06503555A (ja) 1994-04-21

Similar Documents

Publication Publication Date Title
IT1218469B (it) Polipeptide umano fisiologicamente ettivo
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
IL61037A0 (en) Biologically active peptides
IT8049654A0 (it) Procedimento per la preparazione di collageno biologicamente attivo ma cromolecolare e prodotto ottenuto
MX7531E (es) Proceso biotecnologico para alterar la proliferacion y/o el desarrollo de cultivos tisulares
EP0420649A3 (en) Stabilized aqueous formulations of small peptides
ITMI912432A1 (it) Procedimento e apparecchiatura per la fermentazione di amminoacidi
HK1001004A1 (en) Bpc peptides their preparation and use
AU6698786A (en) Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
GR3025679T3 (en) Vaccines
MY106352A (en) Hemoregulatory peptides.
DK354389D0 (da) Polypeptid
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
IT8647912A0 (it) Procedimento enzimatico per preparare l'amminoacidi contenenti zolfo
GB2037161B (en) Preparations containing amino acids
AR241066A1 (es) "saborizante de setas y procedimiento para obtenerlo."
AU8235291A (en) Lyophilized native collagen sheets comprising cosmetic formulations for the treatment of couperose
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
IT1164027B (it) Procedimento per la preparazione di cloridrati di amminoacidi e bicloridrati di diamminoacidi
IT1203299B (it) Procedimento e dispositivo per la preparazione di un materiale di base per la produzione di un preparato biologicamente attivo,quale pepsina o mucina,dallo stomaco di maiali
EP0253245A3 (en) Biologically active peptides tan-866
JPS5668651A (en) Novel biologically active peptide
DE69635457D1 (de) Deprenyl induziertes protein
IT1191649B (it) Procedimento e prodotto reodoranti repellenti per animali
DK198990D0 (da) Biologisk aktivt polypeptid og fremgangsmaade til omdannelse af dette til et modent protein